REGENERON PHARMACEUTICALS, INC.
(REGN)CIK 872589 · SEC filings only
shown as history
Dividend record — shown as history, not graded
A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.
Dividend record
6 declarations · 1 raised · 4 held · 0 cut · held 5 quarters
harness minimum not met
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (3)
$1Bn Share Repurchase Program
Announced $3B share repurchase authorization in November 2021
Deploy excess cash to opportunistically repurchase shares
harness minimum not met
Sector median (Life Sciences): B across 7 graded companies
Not enough comparable guidance to grade
0 of the 4 resolved guidance promises needed to publish a reliability grade. Some of this company’s guidance has no reported figure we can compare it with. It is shown below, never scored; the line under each statement says why. Here's what we're tracking — we never show a grade we can't back with receipts.
guidance history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance by basis
No guidance figure from this company has been graded or dropped for basis yet.
| Guidance type | Said | Graded | Dropped | Other |
|---|---|---|---|---|
| Revenue · basis not stated | 1 | 0 | 0 | 1 |
Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.
Guidance shown, not graded (1)
We show what was said — with its source filing — but never score it. The line under each statement says why.
- revenue guidance fy · Jan 8, 2024Libtayo poised to exceed $1 billion in global net product sales in 2024Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗